Medical News

RSS

Fructose stimulates reward system in the brain to a lesser degree than glucose

Fructose not only results in a lower level of satiety, it also stimulates the reward system in the brain to a lesser degree than glucose. This may cause excessive consumption accompanied by effects that are a risk to health, report researchers from the University of Basel in a study published in the scientific journal PLOS ONE. Various diseases have been attributed to industrial fructose in sugary drinks and ready meals.

26 Jun 2015

Experimental new treatment approach can send deadly leukemia into remission

An experimental new treatment approach for a rare, deadly leukemia can send the disease into remission even in patients for whom the standard therapy has failed, buying them more time to have the stem cell transplant that could save their lives, a small pilot study has found.

26 Jun 2015

Weight loss, combined with vitamin D supplements, reduces chronic inflammation

For the first time, researchers at Fred Hutchinson Cancer Research Center have found that weight loss, in combination with vitamin D supplementation, has a greater effect on reducing chronic inflammation than weight loss alone. Chronic inflammation is known to contribute to the development and progression of several diseases, including some cancers.

26 Jun 2015

New QUT research confirms that friends influence alcohol consumption

Friends can be a dangerous influence, with new QUT research confirming what many drinkers already know - that drinking with mates can push you to drink more.

26 Jun 2015

Pilot antibiotic program at pediatric long-term care facility decreases use of topical antibiotic

A pilot antibiotic stewardship program at a pediatric long-term care facility brought about a 59 percent decrease in use of a topical antibiotic and an 83 percent decrease in orders for antibiotics without proper documentation during a six-month period, according to a new study.

26 Jun 2015

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

The Feinstein Institute for Medical Research and Molecular Medicine announced today that the fourth Anthony Cerami Award in Translational Medicine will be conferred to Thomas E. Starzl, MD, PhD, professor of surgery at the University of Pittsburgh School of Medicine. The award is in recognition of his research in organ transplantation and alloengraftment mechanisms.

26 Jun 2015

QUT researcher reveals how compulsive snacking can be a major cause of weight gain

A QUT researcher has had an article on how compulsive snacking is a major cause of weight gain published in the international journal Eating Behaviors.

26 Jun 2015

Artificial blood technology may help fight disease-transmitting mosquitoes in resource-limited areas

A "nuisance" is probably one of the nicest things people call mosquitoes. Mosquitoes have been called the deadliest animal on the planet, because of the diseases they spread.

26 Jun 2015

Alabama scientists show how phytochemical in magnolia works against head and neck cancers

Magnolias are prized for their large, colorful, fragrant flowers. Does the attractive, showy tree also harbor a potent cancer fighter?

26 Jun 2015

E2F4 biomarker can help predict prognosis and response to BCG therapy in bladder cancer

Investigators from Dartmouth's Norris Cotton Cancer Center harnessed genomic data to discover that the previously identified E2F4 signature in breast cancer can be utilized to predict prognosis and response to therapy in bladder cancer.

25 Jun 2015

Open windows can be extremely dangerous for young children

The dog days of summer are here. But as we try to catch a cool breeze, that open window can become a dangerous hazard for children. In fact, emergency rooms treat more than 5,000 children each year for injuries related to falls from windows.

25 Jun 2015

Long-acting injectable antipsychotic medication benefits people with schizophrenia

Schizophrenia, which affects 2 million to 3 million people in the U.S., causes hallucinations, delusions and disorganization. Left untreated, the disease can cause a significant loss in quality of life, including unemployment and estrangement from loved ones. But many people with schizophrenia can control the disorder and live without symptoms for several years if they consistently take prescribed antipsychotic medication, typically a daily pill.

25 Jun 2015

UIC researchers identify molecular mechanism that directs embryonic stem cells to turn into endothelial cells

Researchers at the University of Illinois at Chicago have identified a molecular mechanism that directs embryonic stem cells to mature into endothelial cells -- the specialized cells that form blood vessels. Understanding the processes initiated by this mechanism could help scientists more efficiently convert stem cells into endothelial cells for use in tissue repair, or for engineering blood vessels to bypass blockages in the heart.

25 Jun 2015

UC Riverside researchers explore effects of early-life exercise

More than one in three adults in the United States is considered to be obese. What impact can exercise done early in life have on the propensity for exercising during the adult years? A team of researchers at the University of California, Riverside did experiments on mice in the lab to find out. Specifically, they evaluated the effects of early exercise on adult physical activity, body mass, food consumption and circulating leptin levels.

25 Jun 2015

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris Inc. announced today that it has executed a definitive agreement with Ergomed PLC, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD").

25 Jun 2015

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.

25 Jun 2015

Medical News

Fructose stimulates reward system in the brain to a lesser degree than glucose

Experimental new treatment approach can send deadly leukemia into remission

Weight loss, combined with vitamin D supplements, reduces chronic inflammation

New QUT research confirms that friends influence alcohol consumption

Pilot antibiotic program at pediatric long-term care facility decreases use of topical antibiotic

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

QUT researcher reveals how compulsive snacking can be a major cause of weight gain

Artificial blood technology may help fight disease-transmitting mosquitoes in resource-limited areas

Alabama scientists show how phytochemical in magnolia works against head and neck cancers

E2F4 biomarker can help predict prognosis and response to BCG therapy in bladder cancer

Open windows can be extremely dangerous for young children

Long-acting injectable antipsychotic medication benefits people with schizophrenia

UIC researchers identify molecular mechanism that directs embryonic stem cells to turn into endothelial cells

UC Riverside researchers explore effects of early-life exercise

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Hallam Assistant Dean to head national health and care regulator

Ebola diagnosis now possible within minutes

World MRSA Day Kickoff Event and Global C. difficile Summit to be held on September 26, 2015 in Illinois

Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News